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Abstract
Background: Up to 40% of the world’s population is at risk for Plasmodium vivax malaria, a disease that imposes a major
public health and economic burden on endemic countries. Because P. vivax produces latent liver forms, eradication of P.
vivax malaria is more challenging than it is for P. falciparum. Genetic analysis of P. vivax is exceptionally difficult due to
limitations of in vitro culture. To overcome the barriers to traditional molecular biology in P. vivax, we examined parasite
transcriptional changes in samples from infected patients and mosquitoes in order to characterize gene function, define
regulatory sequences and reveal new potential vaccine candidate genes.
Principal Findings: We observed dramatic changes in transcript levels for various genes at different lifecycle stages,
indicating that development is partially regulated through modulation of mRNA levels. Our data show that genes involved
in common biological processes or molecular machinery are co-expressed. We identified DNA sequence motifs upstream of
co-expressed genes that are conserved across Plasmodium species that are likely binding sites of proteins that regulate
stage-specific transcription. Despite their capacity to form hypnozoites we found that P. vivax sporozoites show stage-
specific expression of the same genes needed for hepatocyte invasion and liver stage development in other Plasmodium
species. We show that many of the predicted exported proteins and members of multigene families show highly
coordinated transcription as well.
Conclusions: We conclude that high-quality gene expression data can be readily obtained directly from patient samples and
that many of the same uncharacterized genes that are upregulated in different P. vivax lifecycle stages are also upregulated
in similar stages in other Plasmodium species. We also provide numerous examples of how systems biology is a powerful
method for determining the likely function of genes in pathogens that are neglected due to experimental intractability.
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Introduction
Renewed efforts to combat malaria have focused on the goal of
total eradication. While most attention is on the more deadly
Plasmodium falciparum malaria, Plasmodium vivax is the most
geographically widespread human malaria parasite causing an
estimated 80–250 million cases of vivax malaria each year [1]. P.
vivax malaria has traditionally been found outside of tropical areas
and was endemic throughout North America and Europe until the
introduction of DDT. Despite the large burden of disease caused
by P. vivax, it is overlooked and left in the shadow of the enormous
public health burden caused by P. falciparum in sub-Saharan Africa.
The widely held misperception of P. vivax as being relatively
infrequent, benign, and easily treated explains it’s nearly complete
neglected across the range of biological and clinical research. In
fact, P. vivax malaria seriously threatens more people than has been
historically appreciated. Recent reports [2–4] provide abundant
evidence that challenge the paradigm that P. vivax infection causes
benign disease: P. vivax malaria may result in severe symptoms
similar to P. falciparum. Selective pressure for resistance to malaria
has had a great influence on the human genome and most Africans
are immune to P. vivax malaria due to mutations in the Duffy
receptor that the parasites use to invade the red cell.
A fundamental difference between P. vivax and P. falciparum is
the formation of dormant liver stage parasites called hypnozoites
that are resistant to schizonticidal drugs that kill erythrocytic stage
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experience multiple relapses months or years following the
primary infection. Attempts to eradicate malaria will depend on
having effective and non-toxic drugs that target P. vivax liver stage
hypnozoites. Hypnozoite biology is poorly understood but is likely
related to persistence of the parasite in locales where mosquito
populations vary seasonally. Little is known about what triggers a
relapse but some strains form different numbers of hypnozoites
and have different relapse frequencies, which may be correlated
with latitude[5]. There is controversy about whether hypnozoites
represent a different lifecycle stage or merely represent an arrested
early exo-erythrocytic phase. Almost nothing is known about
metabolic activity in the hypnozoite, thwarting all efforts at
rationale drug design. The mechanism of the only drug known to
eradicate hypnozoites, the 8-aminoquinoline drug, primaquine, is
still not completely understood.
While rodent models have furthered our understanding of
Plasmodium liver stage development, they do not form hypnozoites.
The only other available model for studying hypnozoite biology is
the closely related P. cynomolgi species that must be studied in the
rhesus macaque. Studies of P. vivax biology still depend on
obtaining erythrocyte stage parasites or sporozoites from infected
humans or non-human primates or their mosquito vectors,
respectively. Drug sensitivity testing remains difficult. In an earlier
era compounds were tested for activity against hypnozoites in
prisoners who had been given malaria [6]. Drug testing in vitro is
limited by current difficulties in culture techniques. Only a few
genetic manipulations of P. vivax have been successful [7]. These
impediments have discouraged many researchers from working on
P. vivax, and limited the potential for molecular genetic analysis of
this elusive liver stage.
Given that forward and reverse genetic methods, which have
been powerful in P. falciparum, are not readily available for
investigating the genome of P. vivax, comparative genomics and
virtual genetic methods offer the best opportunities to elucidate P.
vivax gene function. Previous gene expression profiling of P.
falciparum [8,9] P. yoelii [10] throughout many developmental life
cycle stages in the mammalian host and insect vector, and in P.
vivax blood stages [11,12] has provided fundamental insight into
Plasmodium biology and illustrated how gene function can be
predicted based on gene expression patterns throughout develop-
ment. The power of this method is to assure that there is sufficient
diversity in different stage parasites to allow for the delineation of
distinct patterns of gene expression.
Here we used a systems biology approach to characterize the P.
vivax transcriptome. Using a custom high-density tiling microarray,
we obtained a diverse set of gene expression data from human and
mosquito stages including sporozoites, gametes, zygotes and
ookinetes, and in vivo asexual blood stages obtained from infected
patients in the Peruvian Amazon. These data are combined with
published short term in vitro culture data [11]. Using a guilt-by-
association approach we create hypotheses about the function of
many uncharacterized genes. Comparison to datasets of P.
falciparum and P. yoelii reveals conserved and species-specific
patterns. This analysis provides new insights into the metabolic
state of parasites growing within humans. It shows that many of
the orthologs of P. falciparum transcripts needed for exo-
erythrocytic development are present in the P. vivax sporozoites
suggesting that slight modifications in exo-erythrocytic develop-
ment may allow hypnozoite formation.
Materials and Methods
Ethics statement
The protocol used to collect human blood samples for this work
was approved by the Human Subjects Protection Program of The
Scripps Research Institute, and the University of California, San
Diego and by the Ethical Committees of Universidad Peruana
Cayetano Heredia and Asociacion Benefica PRISMA, Iquitos,
Peru. Written informed consent was obtained from each subject or
the parent, in the case of minors. The consent form states in
English and Spanish that samples may be used for any scientific
purpose involving this or any other project, now or in the future
and that the samples may be shared with other researchers.
Collection of patient samples and preparation of parasite
cells
Patients who presented to local health clinics in the Peruvian
Amazon region of Iquitos with typical signs and symptoms of
malaria were evaluated by light microscopy examination of
Giemsa-stained blood smears to have P. vivax parasitemia. After
informed consent, 20 ml of blood was drawn into heparinized
vaccutainer tubes, placed in a portable incubator maintained
between 37 and 39uC, and transported to laboratory facilities
within 30 minutes. Blood was centrifuged at 9006g for 5 minutes
and plasma was removed. Red cells were resuspended in 2
volumes of suspended animation (SA) solution (10 mM Tris,
170 mM NaCl, and 10 mM glucose pH 7.4) and passed through a
cellulose column (CF-11 powder, Whatman Ltd) placed in a 37uC
incubator, to remove white blood cells. Asexual parasites were
enriched by gradient purification. Following filtration, cells were
washed twice in SA solution at 900 g for 5 minutes and then
resuspended in a 1:3 v/v ratio in SA solution. For the production
of gametes/zygotes and ookinetes in vitro, The red cells containing
parasites were resuspended in exflagellation medium (10 mM Tris,
170 mM NaCl, 10 mM glucose, 25 mM NaCO3, 10% AB+
human serum, 50 mM xanthurenic acid) to induce parasite
emergence from gametocytes, exflagellation and fertilization.
The cell suspension was then layered over a discontinuous
gradient of 38%, 42% and 50% Percoll (Sigma, USA) in RPMI
1640 medium (Invitrogen USA) and centrifuged at 600 g for 15
minutes. Female gametocytes at the 38–42% interface were
removed from the gradient. Red cells containing asexual parasites
which sediment below the gradient were collected and washed
separately in SA solution at 900 g for 10 minutes. Zygotes and
ookinetes and untransformed gametes at the 11%–16% interface
Author Summary
Most of the 250 million malaria cases outside of Africa are
caused by the parasite Plasmodium vivax. Although drugs
can be used to treat P. vivax malaria, drug resistance is
spreading and there is no available vaccine. Because this
species cannot be readily grown in the laboratory there are
added challenges to understanding the function of the
many hypothetical genes in the genome. We isolated
transcriptional messages from parasites growing in human
blood and in mosquitoes, labeled the messages and
measured how their levels for different parasite growth
conditions. The data for 5,419 parasite genes shows
extensive changes as the parasite moves between human
and mosquito and reveals highly expressed genes whose
proteins might represent new therapeutic targets for
experimental vaccines. We discover sets of genes that are
likely to play a role in the earliest stages of hepatocyte
infection. We find intriguing differences in the expression
patterns of different blood stage parasites that may be
related to host-response status.
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stored at 270uC. Microscopic analysis of cellular morphology
confirmed the enrichment of sexual stages. Small aliquots of
purified cells were stained and 60 fields were examined to
determine the relative percentage of asexual and gametocyte cells
(Table 1). Red cells from asexual enrichments were subjected to
lysis by a 0.1% Saponin solution in PBS for 15 minutes at 4uC.
Parasites were pelleted at 1200 g for 5 minutes and washed three
times in PBS before resuspension in Trizol and storage at 270uC
for shipment to the Scripps Research Institute.
P. vivax whole genome-tiling microarray design
We designed a Affymetrix custom P. vivax whole-genome tiling
microarray with 4.2 million 25-bp probes covering both strands at
six base pair spacing, based on the genome assembly of 2809
contigs (PlasmoDB Ver. 5.4). This microarray includes 1.7 and 2.3
million probes uniquely mapped to coding regions and non-coding
regions, respectively. Altogether 5419 P. vivax genes are repre-
sented on the array, 4676 of which have P. falciparum orthologs.
This array will be made available for purchase from Affymetrix,
part number PvivaxLi520507.
RNA preparation and microarray hybridization
RNA was purified by Chloroform extraction and isopropanol
precipitation and purified by RNeasyMini Kit (Qiagen) following the
manufacturer’s instructions. RNA was quantified by spectrophotom-
eter and qualitatively analyzed by BioRad Experion RNA StdSens
Analysis kit (BioRad). 1 ug of total RNA from asexual blood stage
parasites was used to produce cDNA in the Two-cycle cDNA
synthesis kit (Affymetrix) and amplified to produce labeled cRNA in
the IVT Labeling kit (Affymetrix), and purified using the Genechip
Sample Cleanup Module (Affymetrix), according to manufacturer’s
instructions. For the sporozoite sample, 100 ng of total RNA was
used to produce cDNA in the Two-cycle cDNA synthesis kit
(Affymetrix) and amplified to produce labeled cRNA in the IVT T7
MEGAScript kit (Affymetrix). Following the first IVT reaction, the
cRNA was split into two reactions, containing approximately 500 ng
each for the second round of cDNA synthesis and amplified to
produce labeled cRNA in the IVT Labeling kit (Affymetrix), and
purified using the Genechip Sample Cleanup Module (Affymetrix),
according to manufacturer’s instructions. 20 ug of amplified cRNA
was hybridized to the P. vivax tiling microarray for 14 hours. The
genechips were washed on Affymetrix Wash Station using standard
Affymetrix protocol FlexGE-WS450_00001 and scanned on the
Affymetrix scanner. The Affymetrix CEL files microarray data are
available for download from our companion website (http://carrier.
gnf.org/publications/Pv). Gene expression data are also visible in
PlasmoDB on the P. vivax gene info pages. For more information on
gene expression interpretation from our custom whole genome tiling
a r r a yp l e a s es e et h ew e b s i t e .
Differential gene expression and OPI analysis
All gene expression values were subjected to a probe-level two-
way ANOVA test to determine variability of expression across all
samples [13]. A total of 4,326 genes were identified as differentially
expressed with pANOVA ,0.05 and FC .2 (Table S1) and were
subjected to further OPI clustering analysis. All data can be
downloaded from the companion web site.
Table 1. P. vivax blood sample asexual profile and stage specificity.
Asexual Sample Asexual Group Rings and Early Trophs Schizonts Gametocytes % Asexuals % Gametocytes
CM008 1 169 0 0 100% 0%
CM101 1 240 0 19 93% 7%
CM108 1 292 0 36 89% 11%
CM109 1 143 0 22 87% 13%
CM114 1 316 0 20 94% 6%
CM115 Unique 82 0 20 80% 20%
CM012 2 148 0 88 63% 37%
CM013 2 291 0 36 89% 11%
CM008 Filtered 1 108 0 0 100% 0%
CM101 Filtered 1 73 0 8 90% 10%
CM108 Filtered 1 201 0 7 97% 3%
CM109 Filtered 1 112 0 6 95% 5%
CM114 Filtered 1 332 0 14 96% 4%
CM115 Filtered Unique 101 0 17 86% 14%
CM012 Filtered 2 139 0 19 88% 12%
CM013 Filtered 2 37 0 1 97% 3%
Sexual Stage Gametes Total % Zygotes Total % Ookinetes Total %
Gamete/Zygote 101 80% 26 20% 0 0%
Ookinete 0 0% 7 9% 68 91%
Parasite cell stages present in each patient blood sample at time of collection are listed first. Numbers of cell stages were based on counting microscope 100X objective
view fields until researchers observed a total of 200 white blood cells. Filtered sample numbers indicate the parasite cell stages present in 20 fields in each sample
following filtration to remove white blood cells and Percoll gradient centrifugation to enrich for asexual stages. All asexual samples contained rings and early
trophozoite stages, with no late trophozoites or schizonts. Percoll gradient centrifugation reduced gametocytes in all asexual samples, but a small percentage remained
in the sample from which RNA was prepared. Sexual stage sample data indicate parasite cell stages following in vitro cultivation present in 30 fields at the time of RNA
sample collection. All samples were collected between November 2007 and July 2008 and were not checked for clonality.
doi:10.1371/journal.pntd.0000653.t001
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downloaded from PlasmoDB (version 6.1). Function annotation
data for P. falciparum, P. yoelii, P. vivax, P. berghei, P. chaubaudi and P.
knowlesi were obtained from PlasmoDB, then merged with P.
falciparum function annotation data from Gene Ontology (Novem-
ber 2009 release). We had previously collected gene co-citation
data through Google Scholar and NCBI [10], this dataset is
appended with co-citation data found in ‘‘gene notes’’ section of
the PlasmoDB annotation files. We also considered previously
published data such as P. falciparum protein complexes [14], P.
falciparum cell cycle k-means clusters [9], and our own literature-
based annotations [10]. For each gene list, we further recruited
additional gene members that are homologs or orthologs among
Plasmodium species according to the latest OrthoMCL database
(version 3). The final annotation database contains 3,732 gene lists
that contains at least one P. vivax gene, including 2,538 GO
groups, 1,066 literatures, 84 custom GNF lists, 29 complexes and
15 cell cycle clusters. From these 2,002 lists contains at least two
differentially expressed P. vivax genes, therefore were used to create
clusters of co-regulated genes that share gene ontology annotation
using the ontology-based pattern identification (OPI) algorithm
described previously [15-17]. To weight samples correctly,
replicate samples were weighted 50% each and effected counted
as one sample. When our dataset were merged with Bodzech data,
the overall weighting of samples in each data set was adjusted so
that two data sets contributed equally in the clustering analysis.
Visualization of the OPI expression patterns in Figure 1 used
the OPI query pattern data as described previously [17]. Briefly,
the query pattern is the best representative expression pattern of a
given cluster, and was typically derived from common pattern
shared by most of the known GO members of the cluster. Each
query profile is normalized by subtracting the mean and divided
by the standard deviation, a standard practice used for heat map
plotting. The query patterns representing the 192 gene functions
were hierarchically clustered so that related biological processes
are close to each other.
Figure 1. Gene expression patterns of 192 statistically significant cellular function clusters across all 41 P. vivax samples. Each heat
map row represents the common expression pattern shared by its cluster members and these profiles are hierarchically clustered so transcriptionally-
related cellular functions are in close vicinity. For nine selected clusters with distinct life cycle expression profiles, the detailed gene-by-gene
expression heat maps are shown to illustrate the high correlation within any given cluster. Additional evidences collected for each OPI cluster is
summarized in a white-blue heat map. Blue color indicates a favorable piece of evidence, i.e., either the cluster members form statistically significant
protein networks, or the OPI cluster was also found based on previous analyses and reanalyses of the published 54-sample P. falciparum and P. yoelii
life cycle data set [10]. The average Pearson correlation coefficient of the expression profiles of P. falciparum orthologs of the cluster members are
also color coded, so that blue represents a high positive correlation and gray represents a low negative correlation.
doi:10.1371/journal.pntd.0000653.g001
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For each of the 192 statistically significant P. vivax OPI clusters,
we identified the P. falciparum and P. yoelii orthologs of its cluster
members. We then calculated the average pair-wise Pearson
correlation coefficient of the P. falciparum orthologs in a previously
published cell cycle dataset of 2,235 genes. The correlation
coefficients are almost all positive with a median at 0.45. We also
calculated using a similar approach the average correlation
coefficients of the orthologs in a combined P. yoelii and P.
falciparum life cycle dataset. All results are available in Table S2.
For each piece of P. vivax gene function prediction, we checked if
its P. falciparum or P. yoelii orthologs were also predicted to be in the
same function category based on the previous P. yoelii and P.
falciparum life cycle dataset. Both previously published OPI clusters
[10] and new OPI clusters based on the latest gene annotation
database were used in this cross validation analyses. Notice here an
orthlog was considered to be associated with a GO group as long
as it appeared in the group or one of its descendant groups.
Support was found for 89 of the 192 OPI clusters.
Cross validation with published yeast two-hybrid and
literature datasets
We first projected the previously published P. falciparum yeast two-
hybrid protein interaction database into P. vivax by introducing
interactions to all the corresponding P. vivax ortholog pairs using
OrthoMCL version 3. We then constructed a protein network for each
OPI cluster and recorded the size of the network. To evaluate the
statistical significance of the resultant network, we replaced the cluster
members through random sampling and repeated the network
construction process 1000 times. The p-value of the network was
estimated based on the probability of an equal or more complex
network to occur by chance. The whole process was carried out by
either only considering direct protein-protein interactions or including
indirect protein-protein interactions and whichever led to a better p-
value was selected for presentation. An indirect protein-protein
interaction refers to two proteins interact via another protein. A total
of 63 networks were determined to have p-values ,0.05.
It was previously shown that genes co-cited in a literature tend
to be more correlated in their expression profile compared to gene
members of the same GO group, probably due to the careful
review process involved in the publication [10]. Therefore, it could
be worthwhile introducing virtual protein-protein interactions
among genes co-cited. With these virtual interactions appended to
the yeast two-hybrid dataset, we repeated the above network
evaluation processes for non-literature derived OPI clusters and
identified 11 additional networks.
Protein networks were visualized using Cytoscape (Version 6.1),
where nodes can be color coded according to the level of
confidence in their function predictions, and edges can be color
coded to reflect the data sources.
Motif analysis
Statistical enrichment of motifs in upstream regions was
determined using GeneSpring 7.3 software, using the ‘‘search for
regulatory sequences’’ with parameters of 0 to 1000 bases, motif
sizes of 5 to 9 bps and allowing for up to two N’s in the central
region. Only cutoffs with a corrected p-value of less than 0.05 are
reported except for very small clusters.
Preparation and analysis of P. yoelii and P. falciparum
sporozoite RNA
P. vivax sporozoites were obtained from Sanaria, Inc. from
mosquitoes fed on P. vivax infected chimpanzees infected with India
VII strain P. vivax [18]. Sporozoites were dissected from mosquito
salivary glands and purified. Approximately 150,000 sporozoite
cells were used for RNA preparation. Similarly purified sporozoites
of P. falciparum strain 3D7 isolated from mosquitoes infected with in
vitro cultured parasites were also obtained from Sanaria, Inc.
P. falciparum salivary gland sporozoites were obtained from
Sanaria, Inc. P. falciparum sporozoite RNA was isolated and
amplified using Affymetrix kits as described for P. vivax sporozoite
samples. P. falciparum 3D7 strain RNA from in vitro synchronized
trophozoite stage parasites was isolated and amplified as described
for P. vivax samples. Amplified cRNA was hybridized to the Pftiling
array described previously [19].
To validate the expression comparison of genes that are
differentially expressed in sporozoites of P. vivax and P. falciparum,
we performed quantitative reverse transcriptase polymerase chain
reaction(qRT-PCR)on22geneswith orthologsinbothspecies,and
two P. vivax specific genes. Primers used are listed below. All primer
sets were optimized using genomic DNA from 3D7 strain P.
falciparum and Salvador I strain P. vivax at three dilutions of 10 ng/
ul, 1 ng/ul and 0.1 ng/ul to ensure that the amplification threshold
values accurately reflected the difference in DNA template
concentration. Primer sets for the two different species produced
similar threshold Ct values (what does Ct stands for) (+/2 1.5 Ct)
for all primer sets for both species. An additional aliquot of 150,000
sporozoitesforbothP. falciparum and P. vivaxfrom Sanaria,Inc,were
used to isolate total RNA using Trizol as described previously. This
total RNA sample was split into equally into three reactions to
produce single stranded cDNA using reverse transcriptase and a
T7-Oligo dT primer from the cDNA synthesis kit (Affymetrix)
according to manufacturer’s instructions. The single stranded
cDNA was used as template for QRT-PCR reactions using the
primer sets presented. To account for variability in the input cDNA
between different cDNA reactions from the same species, we
normalized the threshold Ct values by the average difference
between reactions across all genes. We cannot know the identity of
any one gene, which is expressed at the exact same level in both
species that can be used to control for variation. However, when
comparing P. vivax and P. falciparum threshold Ct values, we found
that the highest expressed gene (CSP) and lowest expressed gene
(Pv117045 zinc finger)in both species showed very similar threshold
Ct values within 1.5 Ct cycles, which was the within the error
observed by DNA optimization. Our gene expression data from
multiples species, including P. yoelii, as well as proteomic data and
conventional experiments show CSP is often one of the most
abundant proteins in plasmodium sporozoites. It seems safe to use
this in normalization. qRT-PCR reactions were prepared using
SYBRGREENPCRMasterMix(Applied Biosystems)accordingto
manufacturer’s instructions, and were run on Applied Biosystems
TaqMan machine using SDS 2.2.1 software. Threshold Ct values
were determined using default settings and automatic threshold
determination. All amplification results were manually inspected to
ensure that threshold levels were determined within the logarithmic
amplification phase of the reaction for accurate determination of Ct
values. Fold difference between P. falciparum and P. vivax qRT-PCR
determined expression values are equal to 2 raised to the power of
the difference in Ct values between the two species. qRT-PCR
results and primers used are listed in Supplemental Table S2.
The list of P. vivax sporozoite-specific genes used to seed the OPI
cluster includes: S13, MAC/Perforin (PVX_000810, PFD0430c);
SIAP-1 (PVX_000815, PFD0425w); pf52 protein (PVX_001015,
PVX_001020, PFD0215c); ECP1, cysteine protease (PVX_003790,
PFB0325c); asparagine-rich antigen Pfa35-2 (PVX_081485,
PFA0280w); S24, hypothetical protein (PVX_081555, PFA0205w);
TRSP (PVX_081560, PFA0200w); TRAP (PVX_082735,
Transcriptome Analysis of Plasmodium vivax
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S25, kinesin-related protein (PVX_084580, PFL0545w); MAEBL
(PVX_092975, PF11_0486); S1, hypothetical protein (PVX_094625,
PF10_0083); kinesin-related protein (PVX_094710, PFL0545w);
conserved hypothetical protein (PVX_097795, PFE0230w); hypo-
thetical protein (PVX_118360, PF14_0404); circumsporozoite (CS)
protein (PVX_119355, PFC0210c); early transcribed membrane
protein 13, ETRAMP13 (PVX_121950, PF13_0012); S23, conserved
hypothetical protein (PVX_123155, PF08_0088); S4, conserved
hypothetical protein (PVX_123510, PFL0800c); conserved hypothet-
ical protein (PVX_123750, PFL1075w).
Discovery of un-annotated gene expression in P. vivax
To infer gene expression of un-annotated genes in P. vivax,w e
performed a BLAST search of all P. falciparum and P. knowlesi
annotated genes against the P. vivax genome to identify all putative
orthologous genes that may not be annotated in P. vivax. The
BLAST similarity coordinates were used to define the coding
region in P. vivax. We have not validated the coding sequence for
proper gene translation nor have we defined intron-exon
boundaries for these genes. These gene boundary definitions were
used to pick probes to evaluate the level of gene expression from
these regions in the same way as all other annotated P. vivax genes.
These genes were originally named using the GeneID numbers of
their P. falciparum and P. knowlesi orthologs. We have included these
gene expression values for these putative genes in Table S1. We
also performed an analysis of all P. vivax RNA microarray
hybridization data to identify highly transcribed regions of 50 bp
that do not overlap with existing gene annotations. We found a
few of these regions, but they appeared to correspond to additional
exons, intronic regions, or 59 or 39 untranslated regions of existing
genes. One additional gene identified by this method is the
Pv_PF11_0140 gene. We provide putative P. vivax Gene ID
numbers for these genes based on their position relative to existing
flanking genes. We provide a list of these new putative gene
coordinates in Supplemental Table S3.
Results
Sample collection and microarray analysis
Blood samples were collected from eight different P. vivax-
infected patients with uncomplicated malaria in Iquitos, Peru.
Human leukocytes were removed by filtration and P. vivax
gametocytes were separated from asexual stage parasites by
gradient centrifugation. There was only a small proportion of
gametocytes (0–15%) in the final sample (Table 1), so we hereafter
refer to these samples as asexual profiles. By microscopy the
asexual cells in the patient blood samples appeared to be rings and
early trophozoite stages, with no late trophozoite or schizont
stages, likely as the result of natural synchronization in the
Peruvian patients. For one sample, we put the isolated gametocyte
stages into in vitro culture and induced sexual stage development to
obtain a mixed gamete/zygote stage sample and a mostly pure
ookinete stage sample from the patient isolate (Table 1).
Additionally, we isolated salivary gland sporozoites from dissected
mosquitoes fed on an experimentally infected chimpanzee.
We assayed gene expression using a custom P. vivax whole
genome tiling microarray with 4.2 million 25-base pair probes
covering both strands at six base pair spacing. A semi-quantitative
estimate of transcript abundance for each gene could be obtained
with this microarray design because the 5,419 P. vivax genes were
probed by hundreds of independent oligonucleotides. While this
array can be used to find noncoding RNAs, including antisense
RNAs, the labeled cRNA for hybridization was prepared using a
polyA reverse transcriptase priming method that would not give
accurate descriptions of noncoding RNAs and thus we limited our
analysis to predicted coding regions. In order to calculate an
approximate gene expression level, E, we used the MOID
algorithm, which ranks the probe intensity values for the 20
probes at the 39 end of the transcript having similar GC values. It
then assigns the expression value, E, to difference between the
background (computed from thousands of probes with a similar
GC content not predicted to be in the P. vivax or human genome)
and the probe at the 70
th percentile (Table S1). Because the
varying GC content of different P. vivax genes could give rise to
spurious apparent expression levels, extensive optimization of
probe selection was undertaken to ensure robust measurements of
gene expression across all samples. We show that MOID
expression values are not changed by selection of the independent
13
th or 14
th of 20 ranked probes (Methods S1 Figure IIIA).
Additional optimization for different GC contents (Methods S1)
shows that we can select probes from a whole-genome tiling array
to accurately detect gene expression. To verify reproducibility of
our analysis, we analyzed three samples, two asexual and one
sporozoite in two technical replicates each, and obtained Pearson
correlation coefficients of 0.986 to 0.996, indicating excellent
reproducibility, whereas lower correlation is observed between
samples from divergent asexual groups (Methods S1 Figure IIIB-
D). Results were also confirmed by qRT-PCR, and compared to
expressed sequence tags (ESTs), as described in Methods S1.
Genes involved in similar processes are co-expressed
We first sought to address our hypothesis that genes involved in
similar processes would be co-expressed. We identified 4,326
differentially expressed genes using the cutoff of ANOVA p-value
,0.05 and fold change (FC) .2 using the individual probe
intensity values for each gene using just our data. Differentially
expressed genes were clustered using ontology-based pattern
identification (OPI), an algorithm previously used with P. falciparum
and P. yoelii expression datasets [10] (Figure 1A). This algorithm
begins with 2,002 lists of genes sharing a common gene ontology
(GO) annotation, literature co-citation, or other annotated
parasite-specific process, e.g., there are 38 genes known to be
involved in DNA replication. For each group a representative
expression profile vector is computed using E values from all
conditions for all genes in the group. Then all of the 4,326
differentially expressed genes are ranked by the correlation
coefficient calculated between the gene’s expression vector and
the representative expression profile vector. The algorithm then
uses a correlation coefficient optimization routine and creates
expression clusters that contain the largest number of genes with
common annotation and high correlation. In the case of the GO
process ‘‘DNA replication’’ a group of 60 genes is created which
contains 11 of 38 annotated DNA replication genes. The
probability of this distribution occurring by chance is less than
10
213. Similarly, there is less than 10
28 probability of identifying 5
of 15 genes with an annotation of glycolysis in a cluster of 21
genes. In addition to using gene ontologies we also used other
groupings of genes. In a previous analysis of P. falciparum lifecycle
stages [9] we had identified 106 genes upregulated in sporozoites,
which corresponds to 66 P. vivax orthologs in our dataset
(GO:CCYCL01). Of these 35 were found in a group of 366 genes
with a probability of enrichment by chance of 10
220. Overall these
data showed that patterns of gene expression were nonrandom
and that genes with similar functions showed much greater
cohesion than would be expected by chance. Altogether, 121
clusters of highly correlated genes with shared annotation
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publications/Pv).
Previous analysis of P. vivax blood stage gene expression for
parasites taken into synchronous short term culture has been
performed [11] and we compared our results to these. Because this
study involved two color microarrays and did not produce
expression levels, direct comparisons between expression levels
are not possible. However, we could still apply the same OPI
clustering algorithm to the Bozdech data. Clustering of the
Bozdech data (see companion web site) gave less information
about sporozoites and sexual stages but revealed highly significant
functional enrichments, especially within the area of protein
biosynthesis and ribosome function, which is expected because of
the higher sampling throughout the erythrocytic cycle. For
example, 48 or the 58 annotated genes with a predicted role in
cytosolic ribosome (GO:0022626) were found in a cluster of 126
genes, with a probability of enrichment by chances of 10
263. The
data showed that in many cases the same genes that cluster with
‘‘cytosolic ribosome’’ in the Bozdech data also cluster with ‘‘small
ribosomal subunit’’ in our data. The gene, PVX_084645, co-
clusters with ribosomal genes in both cases and is listed as
hypothetical but its P. falciparum ortholog, PF14_0360, is listed as
an eukaryotic translation initiation factor 2A protein and thus its
association with ribosomes is not surprising. PVX_101135, a
hypothetical, clusters with ribosomal proteins in both cases.
BLASTP (p=1.3610
235) shows a strong match to the yeast
protein YOR091W, a protein of unknown function that associates
with ribosomes that interacts with GTPase Rbg1p [20].
We also co-clustered Bozdech data with our data to generate
more accurate predictions of gene function creating a set of 192
different clusters containing between 2 and 493 genes and p-values
between 10
23 and 10
252 (Figure 1, Table S2). Many of our
functional predictions can be cross-validated with previously
published data sets. In particular we checked if the same function
prediction can be made based on combined P. falciparum and P.
yoelii data set, using either previously published OPI clusters [10]
or an updated cluster set using the latest gene annotations. For
each P. vivax cluster we ran permutation tests to see their P.
falciparum orthologs form denser protein networks than what would
be expected by chance using both published two hybrid data [21]
and literature co-citation data [10]. In total, 75 of the 192 OPI
clusters led to protein networks with a p-value less than 0.05 based
on 1000 permutation simulations. For example, PVX_123920, a
putative ubiquitin-activating enzyme e1 clusters with genes
involved in the proteosome regulatory particle in both P. vivax
and in P. falciparum and has two-hybrid support as well [21]. While
there are numerous examples that can be derived from well-
studied processes, the greatest value of this data is in supporting
predictions for genes that may not be found in other model
organisms. PVX_092415 and PVX_113830 cluster with genes
involved in merozoite development in P. falciparum and in P. vivax
(GO:GNF0218) and furthermore, are supported by two-hybrid
interaction studies from P. falciparum (Figure 2). Likewise,
PVX_000945 shows a similar pattern. The Toxoplasma gondii
homolog of this protein has been isolated from rhoptries [22] as
has, the Toxoplasma ortholog of PVX_113800, which also clusters
with genes involved in merozoite development in P. falciparum.
There are numerous examples from pre-erythrocytic stages as
well. Of course, some caution must be used in evaluating the data
because genes involved in two different processes may be co-
expressed (e.g. DNA replication is occurring during gamete
production) and yet be involved in relatively different processes.
Nevertheless this clustering exercise gives functional predictions for
the many uncharacterized genes found in an OPI cluster.
Heterogeneity in patient blood stage samples
Having established the overall quality of the data we examined
the groups of genes that were differentially expressed in any one
stage. While our initial expectation was that patient-derived blood
samples would be relatively homogenous, unexpectedly, we
observed large differences in the expression profiles of asexual
samples with the most pronounced differences observed in genes
involved in glycolysis. While we found little or no differential
expression of the first three enzymes of the pathway: hexokinase
(PVX_114315), glucose-6-phosphate isomerase (PVX_084735)
and 6-phophofructokinase (PVX_099200), the eight remaining
glycolytic enzymes: fructose 1,6-bisphosphate aldolase
(PVX_118255), triosephosphate isomerase (PVX_118495), glyc-
eraldehyde-3-phosphate dehydrogenase (PVX_117321), phospho-
glycerate kinase (PVX_099535), phosphoglycerate mutase
(PVX_091640), enolase (PVX_095015), lactate dehydrogenase
(PVX_116630) and pyruvate kinase (PVX_114445) all showed
very strong differential expression between samples with some
genes showing up to a 100-fold higher expression in some asexual
samples relative to others (Figure 3). These last eight enzymes are
among the top 1% when ranked by transcript abundance in vitro
trophozoites of P. falciparum and are among the top 5% of P. vivax
genes in some samples but not others (Figure 3). These differences
are unlikely to occur by chance (p=1.9610
27 comparing P. vivax
group 1 and group 2 defined in Figure 3 with a paired t-test).
While the high glycolysis samples were the minority (two of eight),
they were more similar to that described in Cui et al. Here 22,236
ESTs from P. vivax-infected Thai blood samples [12] were
sequenced. Our data showed good Spearman rank correlation
with the Thai EST numbers and showed that those samples with
high glycolysis gene E values were most similar (r=0.53) (Table 1
and Methods S1) to the Thai strain. While it may be that these
expression differences are due to contamination with gametocytes
[23] the presence of 0–10% contaminating gametocytes cannot
mathematically explain why lactate dehydrogenase is present at
,3,300 units in two asexual samples and as low as 75 (almost
indistinguishable from background) in others [24]. Furthermore,
genes typically associated with gametocytogenesis (e.g. Pvs25,
PVX_111175) are higher in the high glycolysis samples (CM12
and CM13). An alternative is that although morphologies looked
similar, a substantially different proportion of early and late cell
cycle stages were contained in high and low glycolysis samples.
Genes typically associated with schizogony and invasion such as
myosin motor proteins and reticulocyte binding proteins, tran-
scribed later in the Bozdech erythrocytic cycle data, were
expressed at higher levels in the low glycolysis samples (Figure 1).
Despite this, glycolysis transcripts generally do not show 50–100
fold changes in expression levels throughout the in vitro
erythrocytic cycle in P. falciparum cultured in vitro [8,9] nor are
such large fold changes observed with P. vivax cultured in vitro [11].
In addition, such a hypothesis would require the patient samples to
have been tightly synchronized. While more samples will be need
to be examined, the data raise an intriguing possibility that there
may be differential regulation of metabolism in a subset of patient-
derived samples as observed in P. falciparum patient–derived
samples (Figure 3) [24].
Many of the same transcripts needed for early
intrahepatocyte function in P. falciparum are upregulated
in P. vivax sporozoites
The molecular determinants regulating hypnozoite formation
and relapse are unknown. One hypothesis is that the hypnozoite is
an early stage exo-erythrocytic form (EEF) that is arrested in
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www.plosntds.org 7 April 2010 | Volume 4 | Issue 4 | e653Figure 2. Network analysis. Corresponding P. falciparum orthologs of the cluster members may form statistically significant two-hybrid interaction
networks. Gene members known to be involved in the cluster are colored in green, predicted ones are colored in pink and those supported by OPI
analyses of P. falciparum and P. yoelii life cycle data set are shown in blue. Interaction edges are color coded to reflect whether it is a direct interaction
or an indirect interaction, and whether it has literature co-citation support or not. A complete list of genes with cross-validation is given in Table S3.
doi:10.1371/journal.pntd.0000653.g002
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transcriptional profile of P. vivax sporozoites to be similar to species
that do not form hypnozoites. Thus, we compared our P. vivax
sporozoite expression profile to a P. falciparum sporozoite sample
and three P. yoelii sporozoite samples analyzed previously [25,26].
Sporozoite transcriptome comparisons showed that P. vivax
sporozoites are generally similar to P. yoelii and P. falciparum
sporozoites with positively correlated expression of highly
expressed genes (r=0.5). Despite some species-specific differences,
we observed similar expression for many P. vivax genes whose P.
falciparum and P. yoelii orthologs were previously shown to be
upregulated in sporozoites, including some of the most highly
expressed genes in the P. vivax sample (Table 2): In addition to
genes known to be upregulated in sporozoites such as the initiation
factor UIS1, and the serine threonine phosphatase UIS2, the list
contains a number of known candidates for pre-erythrocytic
subunit vaccines including the apical membrane antigen 1 (AMA1)
gene and the circumsporozoite protein (CSP). In addition there are
genes whose disruption has led to genetically attenuated
sporozoites that may eventually be used in whole organism
vaccines, including the ortholog of P. falciparum etramp10.3 or
UIS4 in P. yoelii [27,28], UIS3 [29] and P52 [30]. From the set of
genes upregulated in multiple species (Table S4) we identified a set
of sporozoite conserved orthologous transcripts (SCOT) that were
upregulated in multiple species but not yet annotated that may
provide a list of possible candidates antigens for P. vivax pre-
erythrocytic vaccines, or which when disrupted may yield
genetically attenuated sporozoites.
There are also, of course, genes which are not found in P.
falciparum that are upregulated in P. vivax sporozoites and may play
some unique role in the biology of P. vivax or other hypnozoite-
forming parasites. Examples from the sporozoite specific com-
bined OPI cluster (GO:GNF0006) include up to 63 genes without
P. falciparum orthologs. There are also some genes previously
shown to be upregulated in P. falciparum sporozoites, but whose
orthologs were downregulated or barely increased in P. vivax
sporozoites or vice versa (Table S4). One ApiAP2 gene
(PVX_090110) and two zinc finger proteins (PVX_099045,
PVX_099045, PVX_081725), which often function as transcrip-
tion factors, were downregulated as were several RNA binding
proteins (PVX_098995, PVX_098995, PVX_100715) and several
kinases including two serine/threonine protein kinases
(PVX_081395, PVX_081395, PVX_002805), a FIKK calcium-
dependent protein kinase (PVX_091755) and a MAP kinase
(PVX_084965). Although some of these differences could be due
to strain specific or sporozoite collection variation we were able to
confirm these species-specific differences in gene expression for 19
genes using qRT-PCR (Table S5).
Genes upregulated in gamete/zygotes are mostly
uncharacterized
The process of sexual development and meiosis are poorly
characterized in many species. An expression profiles from the mix
of macrogametes and zygotes (Table 1) derived from in vitro
cultivation of fertilized patient-derived gametocytes showed
Figure 3. Expression of metabolic genes in P. vivax asexual blood stage parasites. The expression values of each gene in each sample were
normalized by subtracting the average expression value and dividing by the standard deviation across all asexual samples. The glyceraldehyde 3-
phosphate dehydrogenase gene is not annotated but the syntenic region in P. vivax also shows high expression in sample CM013 (Supplemental
Figure 2). Gene expression values were normalized by subtracting the average expression value across all samples and dividing by the standard
deviation of expression values across all samples. The resulting normalized expression values were colored on a scale ranging from 21t o+2, from
black for the lowest, red for the middle, and white for the highest values. The gene ID numbers for glycolysis genes displayed in Figure 3 are: lactate
dehydrogenase (PVX_116630, PF13_0141); enolase (PVX_095015, PF10_0155); glyceraldehyde 3-phosphate dehydrogenase (PVX_117321,
PF14_0598); fructose 1,6-bisphosphate aldolase, putative (PVX_118255, PF14_0425); 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase
(PVX_091640, PF11_0208); triosephosphate isomerase (PVX_118495, PF14_0378). Gene ID numbers for TCA cycle and aerobic respiration genes are:
flavoprotein subunit of succinate dehydrogenase (PVX_111005, PF10_0334); malate:quinone oxidoreductase (PVX_113980, PFF0815w); IRP-like
protein (iron regulatory protein-like) (PVX_083005, PF13_0229); fumarate hydratase (PVX_099805, PFI1340w); ATP-specific succinyl-CoA synthetase
beta subunit (PVX_084960, PF14_0295); 2-oxoglutarate dehydrogenase E1 component (PVX_089325, PF08_0045); dihydrolipoamide acyltransferase
(PVX_119310, PFC0170c); succinyl-CoA synthetase alpha subunit (PVX_091100, PF11_0097); iron-sulfur subunit of succinate dehydrogenase
(PVX_123345, PFL0630w); cytochrome C oxidase (PVX_099845, PFI1375w); cytochrome c oxidase copper chaperone (PVX_111430, PF10_0252);
cytochrome c oxidase subunit II precursor (PVX_084995, PF14_0288); cytochrome c oxidase assembly protein (heme A: farnesyltransferase)
(PVX_080280, PFE0970w); cytochrome c oxidase assembly protein (PVX_084785, PF14_0331); NADH dehydrogenase reaction protein (PVX_119700,
PFC0505c).
doi:10.1371/journal.pntd.0000653.g003
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roles in DNA replication, meiosis and chromatin structure
(Table 3). The majority of strongly differentially expressed genes
are uncharacterized, although many had been shown to be
upregulated during induction of in vitro gametocytogenesis in P.
falciparum[15]. As predicted, high expression of the P. vivax
ortholog of Pvs25 (PVX_111175), the ookinete surface protein,
is found in this stage. Another membrane protein gene, the
ortholog of the Toxoplasma gondii PhIL1 (photosensitized INA-
labeled protein 1) (PVX_081335), was among the most highly
upregulated (.20-fold) in P. vivax gametes/zygotes. This protein
associates with the cytoskeleton and is localized to the apical end of
the plasma membrane [31] where it may function as an ookinete-
specific surface protein for midgut invasion. The transcription
factor high mobility group protein, HMGB2 (PVX_089520) is
found among the top 20 genes expressed in this sample (See Table
S1). It was shown to be a critical regulator of oocyst development
and appears to activate genes that are most highly transcribed in
gametocytes, but then stored and translated in ookinetes [32].
Interestingly, some of these uncharacterized proteins are also
upregulated during meiosis in humans, such as the human
orthologs of PVX_117890 [33]. An exceptionally large proportion
of the genes upregulated in zygotes (Table 3) did not fall into
clusters with enrichments of known genes, highlighting the
problem of using ‘‘guilt by association’’ when the existing
knowledge base is sparse.
Table 2. Most highly expressed P. vivax genes in the sporozoite stage.
Alias Description P. vivax Gene Exp (E) Rank
SCOT1 hypothetical protein, conserved in Plasmodium PVX_122458* 17726 1
UIS4 UIS4, ETRAMP10.3 PVX_001715 16095 2
SCOT2 hypothetical protein, conserved PVX_092505 13536 3
CSP1 circumsporozoite protein precursor, putative PVX_119355 13189 4
PvSpz1 hypothetical protein PVX_092255 8649 5
H3 histone H3, putative PVX_114020 6864 6
SUI1 translation initiation factor SUI1, putative PVX_101080 6656 7
PvSpz2 hypothetical protein, conserved PVX_113796 6201 8
UVS1 hypothetical protein, conserved PVX_089045 5424 9
AMA1 apical merozoite antigen 1 PVX_092275 4856 10
ECP1 cysteine protease serine-repeat antigen (SERA) PVX_003790 4799 11
Falstatin PVX_099035 4358 13
UVS hypothetical protein, conserved PVX_122910 3975 14
PvROM1 rhomboid-like protease 1, putative PVX_091350 3501 15
DIM1 DIM1 rRNA dimethylase, putative PVX_100520 3383 17
hypothetical protein, conserved PVX_087095 3236 18
PvSpz3 hypothetical protein PVX_114765 3074 19
S11 S11 P. yoelii conserved hypothetical protein PVX_086200 3056 20
SCOT3 hypothetical protein, conserved PVX_085040 2794 23
SCOT4 hypothetical protein, conserved PVX_123360 2793 24
DHFR-TS dihydrofolate reductase-thymidylate synthase PVX_089950 2729 25
UVS2 protein tyrosine phosphatase, putative PVX_091305 2713 26
UVS3 hypothetical protein, conserved PVX_115405 2697 27
PvSpz4 hypothetical protein PVX_118250 2688 28
SPECT sporozoite microneme protein, putative PVX_083025 2671 29
G10 G10 protein, putative PVX_080110 2499 32
UIS2 UIS2, Ser/Thr protein phosphatase PVX_117230 2332 34
D13 CCCH zinc finger domain D13 protein PVX_089510 2282 35
UVS4 hypothetical protein, conserved PVX_091250 2273 36
SCOT5 hypothetical protein, conserved PVX_094795 2063 43
S14 S14 P. yoelii Sporozoite-specific gene PVX_084410 2037 46
UVS5 hypothetical protein, conserved PVX_122540 2022 47
PvSpz5 hypothetical protein, conserved in Plasmodium PVX_091306* 1978 50
Selected highly expressed representative sporozoite genes. For complete details, see Table S1 and S3. Genes are ranked in descending order by maximum expression
value in sporozoites. Sporozoite Conserved Orthologous Transcript (SCOT) genes are previously un-annotated or hypothetical genes upregulated in sporozoites of all
Plasmodium species. UVS genes are upregulated only in P. vivax sporozoites, not in P. falciparum sporozoites. PvSpz genes are unique to P. vivax, with no orthologs in P.
falciparum. * Indicates genes that were not previously annotated in P. vivax. PVX_122458 and PVX_091306 are new gene ID numbers according to their relative position
in the genome and the gene models were based on the PKH_141170 and PKH_091040 gene models, respectively (Methods S1).
doi:10.1371/journal.pntd.0000653.t002
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Gene ontology-based OPI clustering revealed few annotated
gene functions to be upregulated in ookinetes. This finding likely
reflects the difficulty of obtaining sufficient quantities of this
developmental stage for in vitro study. We found high expression of
genes involved in chromatin (e.g. histones) and translation,
potentially reflecting the fact that once the parasite reaches the
midgut and forms an oocyst, thousands of rounds of DNA
replication will likely commence. Genes specifically upregulated in
oocysts were mostly uncharacterized. Ookinete surface protein
genes such as the P. vivax ortholog of the CSP and TRAP-related
protein (PVX_095475), previously shown to be essential for
ookinete invasion [34,35], the transmission-blocking target antigen
Pfs230 (PVX_003905), a sexual stage antigen s48/45 domain
containing protein (PVX_003900), the transmission blocking
target antigen precursor Pfs48/45 (PVX_083235), showed modest
levels of upregulation (,3-fold) in ookinetes relative to any other
stage. In P. falciparum, transcripts for many of these peak in early
stage gametocytogenesis [15], and thus high expression would not
necessarily be expected in P. vivax ookinetes, even if protein is
detected in present.
On the other hand there were a number of uncharacterized
genes that showed substantial upregulation in ookinetes (.3-fold).
These may encode the proteins that are needed for early oocyst
formation. Some examples (see Table S1 for details) include a
possible calcium dependent kinase, (PVX_083525), and 5-
aminolevulinic acid synthase (PVX_101195), a key enzyme in
the porphyrin synthesis pathway that leads to heme synthesis.
Proteases and other degradative enzymes may be needed to exit
the blood meal, penetrate the peritrophic matrix or form the
oocyst on the mosquito midgut. A number of proteases were
unregulated in ookinetes, including Ulp1 (ubiquitin-like protein-
specific protease, PVX_100650), which is specifically required for
cell cycle progression in other species.
Drug resistance gene expression
While in many cases drug resistance in malaria parasites is
conferred by single nucleotide polymorphisms [36–38], in some
cases transcript amplification events in a target or in a pump [39]
confer greater tolerance to drugs. We therefore compared levels of
drug resistance gene transcripts to determine if anything
interesting might be found. Most genes involved in drug resistance
such as pvcrt (chloroquine resistance transporter, PVX_087980),
dhps (dihydropteroate synthase, PVX_123230), gtpch (GTP cyclo-
hydrolase, PVX_123830) or mdr1 (multidrug resistance gene 1,
PVX_080100) showed similar patterns in P. vivax and P. falciparum.
Table 3. Genes showing the strongest probability of differential upregulation in zygotes.
Gene Sexual stage ID Description Pf name Panova FC
Zygote E
level
PVX_090155 Yes tubulin alpha chain, putative PFD1050w 5.78E-102 30.1 1434
PVX_090215 No hypothetical protein PFD1110w 2.29E-94 24.9 2588
PVX_111175 Yes ookinete surface protein Pvs25 PF10_0303 2.05E-91 8.0 1882
PVX_101400 Yes PFG377 protein PFL2405c 2.40E-90 30.8 2352
PVX_096190 No hypothetical protein MAL7P1.124 1.03E-89 12.5 1677
PVX_114020 No histone H3, putative PFF0510w 3.78E-87 62.8 18297
PVX_089075 Yes hypothetical protein PF08_0024 4.18E-74 4.2 428
PVX_123425 No hypothetical protein PFL0715w 1.23E-71 10.6 1524
PVX_080425 Yes transporter, putative PFE0825w 1.51E-70 34.8 5350
PVX_118115 N.o.d. hypothetical protein 5.83E-69 44.3 6918
PVX_094510 N.o.d. hypothetical protein 1.44E-63 11.6 3533
PVX_123410 N.c. hypothetical protein PFL0700w 2.37E-60 7.7 933
PVX_117370 N.c. hypothetical protein 2.94E-58 7.7 932
PVX_089570 Yes meiotic recombination protein DMC1-like protein MAL8P1.76 2.90E-57 24.4 3465
PVX_096300 N.c. hypothetical protein MAL7P1.107 2.41E-53 9.7 1636
PVX_085750 N.c. hypothetical protein PF14_0138 1.41E-51 5.2 521
PVX_099960 N.c. hypothetical protein PFI1465w 1.52E-51 12.01 3164
PVX_084615 No DNA replication licensing factor MCM5, putative PFL0580w 5.21E-51 3.0 328
PVX_081335 Yes photosensitized INA-labeled protein 1 PFA0440w 1.43E-49 21.5 3918
PVX_089585 Yes heat shock protein, putative MAL8P1.78 1.46E-49 10.0 1903
PVX_092905 N.o.d. hypothetical protein 1.51E-49 10.9 2081
PVX_082985 N.c. hypothetical protein MAL13P1.211 4.82E-48 8.4 1867
PVX_000675 N.c. hypothetical protein PFD0580c 8.01E-48 6.9 1301
PVX_117890 Yes sortilin, putative PF14_0493 4.72E-45 3.4 205
PVX_113490 N.o.d. hypothetical protein PFF0315c| 1.34E-44 14.8 2976
Sexual stage ID indicates that the P. falciparum or P. yoelii ortholog was part of a group upregulated previously shown to be upregulated during sexual development
[10]. N.o.d. indicates that there was no orthologous data and N.c. indicates that orthologous data exists but that the gene was not found in clusters enriched for genes
involved. Genes were ranked by p-value computed with the ANOVA method.
doi:10.1371/journal.pntd.0000653.t003
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target of the widely used antimalarial antifolate drug, pyrimeth-
amine. Remarkably, dhfr expression was 50-fold higher in the
India VII P. vivax sporozoites (confirmed by qRT-PCR, see Table
S6) and 10-fold to 30-fold higher in P. vivax asexual stages
compared to P. falciparum, where it was near background in all
stages. Interestingly, while P. falciparum is sensitive to pyrimeth-
amine, P. vivax is considered intrinsically resistant [40], although in
vitro drug sensitivity data is not available for most P. vivax strains.
Both dhfr mutations [41,42] and amplifications [43] have been
shown to confer resistance in P. falciparum. Thus, the higher dhfr
expression in P. vivax relative to P. falciparum may confer higher
tolerance to pyrimethamine.
vir genes show lower than average expression
While much of our data shows that patterns of gene expression
are conserved across Plasmodium species the data also reveals
possible roles for information about the many uncharacterized
genes which are specific to P. vivax including members of
multigene families. The largest paralogous gene family of P. vivax
is the diverse superfamily of variant surface protein genes (vir)
found in subtelomeric regions [44] and may be related to the rif
genes of P. falciparum and yir genes of P. yoelii [45]. The highly
variable surface protein var gene family in P. falciparum has no
orthologs in P. vivax. Expression levels for most of the 274 vir genes
on the array were lower than for other genes. The average for vir
genes was 210 units (approximately the 35
th percentile) using the
highest value in any one stage (MaxExp in Supplemental Table 1),
versus 572 units (approximately the 80
th percentile) on average for
other genes. In addition 39 of the 109 genes in the genome, which
were not detected as differentially expressed in any sample, were
vir genes. Only 27 of the 274 probed vir genes showed strong
differential regulation (.5-fold change, pANOVA,0.001) versus
1,044 of the remaining 5,420 genes. Interestingly, four of the
highest expressed vir genes (PVX_086860, PVX_096970,
PVX_096980, PVX_096985) were among the highest expressed
genes in the two high glycolysis asexual samples, indicating
possible alternate mechanisms of expression control. Three of
these highly expressed vir genes are adjacent to one another
suggesting coordinated regulation of the entire region. Cui et al.
also found these three vir genes and another gene in the same
region (PVX_096975) had the highest numbers of ESTs in their
patient samples [12].
Most highly expressed members of multigene families
are co-transcribed with exported proteins
Malaria parasites are known to be able to decorate the surface
of infected erythrocytes with proteins that play roles in
sequestration and immune evasion. Many of the exported proteins
contain sequences, called PEXEL or VPS motifs that direct them
out of the parasitophorous vacuole and to the surface [46,47] and
many are members of multigene families, presumably because
enhanced levels of recombination between members or epigenetic
transcriptional switching between members allows the parasite to
evade the host immune responses to these exposed proteins. Many
of the exported genes in P. falciparum are transcribed at specific,
mid-trophozoite stages of the parasite cell cycle [47]. The number
of predicted exported proteins in P. vivax is not as large as in P.
falciparum most likely due to problems in recognizing PEXEL/VPS
motifs in this species. For example, only 160 of the 346 vir proteins
contain predicted export motifs [48]. In addition to vir genes the
20 members of the P. vivax PHIST (Plasmodia helical interspersed
subtelomeric) exported gene family (Pv-fam-b)[49] on the array
are expected to be exported as well as some members of the Pv-
fam-h and Pv-fam-e families.
Remarkably many of the members of the multigene families as
well as most predicted exported proteins that show strong
differential transcription show peak expression in just one of our
blood stage samples, CM115 (Figure 4). Five of the eight exported
PHIST genes, six of the ten of Pv-fam-e family of RAD GTPases
(some exported), nine of the 11, Pv-fam-d, and 9 or the 11 Pv-fam-
a genes that show strong (.5X) differential expression again peak
mostly in CM115. While vir genes show lower levels of expression
overall, many of those that are differentially expressed also peak in
CM115. Notably, 17 of the 38 expressed above 300 units show
peak transcript levels in sample CM115. Many of the genes
showing dramatic upregulation (up to 100 fold) in sample CM115
are abundantly transcribed. The Pv-fam-d family with 16 genes of
unknown function has 2 genes in the top 1% of all genes ranked by
maximum expression as does the Pv-fam-a family of tryptophan
rich antigens (PvTRAg, average max expression in any one
sample =1,969 units). One P. vivax tryptophan-rich antigen,
PvTRAg (PVX_090265), has shown a very high seropositivity rate
for the presence of antibodies in P. vivax malaria patients [50].
Another highly immunogenic antigen in this multigene family is
PvATRAg74 (PVX_101510), recombinant versions of which
showed erythrocyte binding activity and were recognized by all
P. vivax patient sera tested [51]. This gene also ranks in the top 1%
of transcripts in CM115. Many of the exported genes in P.
falciparum are transcribed at specific, mid-trophozoite stages of the
parasite cell cycle [47] and it seems likely that most of the parasites
in asexual sample CM115 are at this export permissive stage. Thus
many of the genes that are specifically upregulated in CM115 may
play a role in immune evasion. While genes involved in DNA
replication are also upregulated in CM115, these same genes are
also upregulated in zygotes, while those encoding exported
proteins may not be. These data nicely illustrate how the random
collections of gene expression data that may be obtained from a
neglected parasite can be used to create high quality predictions if
enough random and yet diverse data is available. The data also
illustrate that an advantage of using P. vivax patient samples is that
a high level of synchrony may exist, that is confirmed by the
Bozdech data (Figure 4).
Of course members of multigene families that share sequence
similarity may have different cellular roles depending on their
expression in the parasite lifecycle. An example is the group of
cysteine protease genes referred to as serine repeat antigens
(SERAs). In P. falciparum, PFB0325c, one of the seven SERA genes
is expressed in sporozoites, while the others are expressed in blood
stages. Disruption of this SERA ortholog, called ECP1 in P. berghei,
results in parasites that are unable to migrate out of the oocyst[52].
Although P. vivax contains 13 SERA cysteine protease paralogs,
only the ECP1 ortholog (PVX_003790) was dramatically upregu-
lated in sporozoites (105X). Two others showed substantial
upregulation in sample CM12. None of the SERAs show maximal
expression in sample CM115, nor do any members of the Pv-fam-
c, homologous to the SURFIN gene family in P. falciparum. These
are not appreciably expressed in any of our samples and may be
functioning in other life stages.
Exploring transcriptional regulatory circuits
In many organisms, including Plasmodium species, genes that are
co-expressed share common sequence motifs in the regions
upstream of their translational start sites [16]. To determine
whether this would be true in P. vivax we looked for enriched motifs
in various OPI groupings created with our data or the combined
larger dataset. Here all possible 6–9 mers are counted within a
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number found in all upstream regions. A corrected p-value that
accounts for the multiple testing hypothesis is then computed. In
general we find that transcriptional control is conserved and that
manyofthesame motifs,whichappeartocontrol geneexpressionin
P. falciparum also appear to control gene expression in P. vivax. For
example an unbiased search for overrepresented sequences
upstream of the 70 sporozoite-specific genes with promoter
sequences (GO:GNF0006) relative to upstream regions in the
whole genome found a motif similar to one associated with P.
falciparum sporozoite genes. This putative regulatory sequence,
TGCATG, is found upstream of 44 of the 70 P. vivax sporozoite-
specific OPI cluster genes. The corrected probability of enrichment
by chance in this set relative to the rest of the upstream regions in
the genome is 0.02. Additionally, 48 of 65 genes in the list of SCOT
genes contained the TGCATG motif (Table S6, p=9.16610
27).
This is similar to the PfM24.1 sporozoite-specific regulatory motif
CATGCAG identified in P. falciparum [16], sharing the core
CATGC sequence and identical to the sequence (Table S6) bound
by the P. falciparum ApiAP2 transcription factor PF14_0633 [53].
The P. yoelii ortholog of this transcriptionfactor (PY00247) is among
the highest expressed genes in midgut sporozoites [10], supporting
the hypothesis that this protein functions as a specific activator of
sporozoite transcription [25].
A rich variety of other promoter motifs could be found by searching
the various other OPI clusters as well. The sequence TGTAnnTACA
was found enriched in the 1000 bases upstream of 383 genes from an
OPI cluster containing 12 of the 19 genes mentioned in a an analysis
of P. falciparum sexual development (GO:PM16005087, 92/364 genes,
p=1.69 610
226). This motif (Figure 5) is identical to the motif that is
found in 65 of the 246 genes upregulated during sexual development
in P. falciparum [15]. A cluster of genes enriched for ones with a role in
gliding motility gave the motif TGTnnACA (86 or 155 genes,
p=0.00224). A search of a cluster with many genes predicted to be
involved in merozoite development (GO:GNF0218) produced the
motif GTGCA in 392 of 443 genes with a probability of enrichment
by chance of 4.31610
213. Protein binding microarrays have shown
that the P. falciparum AP2 transcription factor, PFF0200c binds this
motif [53]. It is also found upstream of P. falciparum genes transcribed
during schizogony [16]. As with P. falciparum [54] the sequence
CACAC was enriched in a cluster of genes containing an abundance
of DNA replicationgenes (GO:0030894,192 of 228 promoterregions,
p=4.7 610
26). Novel motifs were also found. A cluster enriched for
genes identified in a male gametes (GO:PM16115694 [55]) yielded
the motif CGTACA in 35 of 66 genes (p=0.0645) and the sequence
GCTATGC was found upstream of 36 of the 105 genes with
promoter sequences in the cluster containing many of the structural
constituents of the ribosome (GO:0003735, p=0.007). This motif is
similar to binding site for the AP2-O transcription factor (TAGCTA)
that functions as a positive regulator of ookinete gene expression [56].
While these motifs may not be the same, expression of ribosomal
proteins is upregulated in ookinete stages and one must keep in mind
that transcription factor binding is likely to be combinatorial and a
given gene may have multiple regulatory sites contained within its
upstream region.
Discussion
Analysis of the transcriptome of blood stages and sporozoites of
P. vivax shows that the general mechanisms of growth, develop-
Figure 4. Co-expression of members of multigene families. Our entire dataset as well as that of Bozdech (TP samples) from three samples of
parasites taken into short term culture were combined and subjected to hierarchical clustering. A portion of the dendrogram is expanded. In contrast
to other areas of the dendrogram almost all genes are hypotheticals or members of multigene families, may of which are likely to be exported. Gray
areas indicate experiments for which no data is available.
doi:10.1371/journal.pntd.0000653.g004
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Plasmodium species. Some of the expression differences that exist
between species may provide insight into the molecular and
genetic basis of biological differences that distinguish the species.
The most significant differences include the formation of
hypnozoites by P. vivax, pathogenic processes of sequestration
and antigenic variation, and the wider geographical distribution of
P. vivax into temperate regions. However, examination of a much
larger number of different strains will probably be need to
determine which differences of the differences we find are likely to
be due to speciation and which are due to strain or experiment
variability.
Because of the difficulties of working with P. vivax, transcrip-
tional and proteomic studies represent one of the most effective
Figure 5. Sequence motifs associated with stage specific-expression. A. Figure showing different motifs associated with different lifecycle
stage expression. B. Alignment of promoter regions showing the sexual development motif. The motif TGTAnnTACA was discovered in
GO:PM16005087 in 92 of the 364 genes promoter regions. While the majority of the 92 genes were hypothetical, the 22 with a predicted function are
shown here. Distance is the number of bases upstream of the translational start site.
doi:10.1371/journal.pntd.0000653.g005
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of the genes that cluster with proven antigens for pre-erythrocytic
vaccines such as CSP may be worth investigating especially if sera
drawn from individuals living in P. vivax endemic regions shows
cross reactivity to their cognate protein [57]. A high-throughput
analysis P. falciparum proteomic data [58] revealed one exception-
ally abundant sporozoite protein named Ag2 in P. falciparum [59]
or CelTos in P. berghei [60], which was more immunogenic than
previously identified antigens such as CSP. In P. falciparum this is
the third most abundant transcript in sporozoites. Ag2 one of the
few antigens that is able to provide cross-species immunity and
indeed we also find it highly expressed in our sporozoite sample.
Given that many of the SCOT genes show strong expression only
in sporozoite stages, their disruption may lead to genetically
attenuated sporozoites that cannot develop in the liver, but which
nevertheless provide immunity.
The gamete/zygote and ookinete expression data provides
insight into mosquito midgut biology of a second human-infecting
malaria parasite, and confirms common stage-specific gene
expression shared by multiple Plasmodium species. Processes of
sexual development, meiosis and DNA replication were evident in
the gamete/zygote transcriptome. Some ookinete surface protein
genes show highest expression in the gamete/zygote stage.
Ookinetes produce stage-specific surface proteins, secreted prote-
ases and invasion-related gliding motility proteins. While we
observe upregulation of many cell-surface genes involved in
invasion in our gametes/zygotes and ookinetes relative to asexual
stages, this conclusion should be considered in light of the fact that
our asexual stage gene expression represented ring and tropho-
zoite stages, but no schizont and merozoite stage gene expression,
thus biasing the analysis against the invasive blood stage parasites.
The function of the vir gene family is still unknown, but
published data seems to indicate its function is fundamentally
different from var genes. While P. falciparum var genes display
mutually exclusive expression only during the mature stages [61],
different vir [11], yir [62] and rif [63] genes are expressed in
different intra-erythrocytic stages and gametocytes [64]. Previous
studies showed that vir expression is not clonal, and multiple vir
subfamilies are expressed in individual parasites from infected
patients [65]. This is supported by our analysis of vir expression in
vivo, with high-level expression of a small subset of vir genes in the
high glycolysis samples along with other genes such as the
PvTRAG genes that are likely involved in antigenic variation and
immune evasion. However, examination of our data will also show
that expression levels for many vir genes was very low or not
detectable, indicated that they may be silenced. It is formally
possibly that none of the parasites that we collected were at a stage
where vir genes are being actively transcribed, potentially because
of sequestration. The overall low levels could also be attributed to
having mixed stage parasites in our samples, however many other
cell-cycle regulated genes such as histones showed strong (.50)
fold differential expression in some of our blood stage samples.
Finally, vir gene genetic differences between the genome reference
strain, Salvador I, and the Peruvian samples [66] could contribute
to reduced expression levels, although high expression was
certainly found for other members of variable gene families.
Excepting these caveats, our data are consistent with a model in
which some vir genes are transcriptionally-silenced.
The OPI analysis here provides functional predictions for a
large numbers of genes. However, its limitation is that it uses
existing knowledge and it is likely that interesting clusters of genes
may be of mixed function, which can be estimated by examining
the false positive and true positive rates in each cluster in
Supplemental Table 2. In some cases the functional enrichment
may be misleading and thus caution should be used in interpreting
the labels. Many of the exported protein and blood stage antigens
are found in an OPI cluster named ‘‘ribonuclease activity’’
reflecting the fact that this is the only well-annotated cellular
process going on at this time. Finally, 501 of the differentially
expressed genes were not contained in any of the OPI clusters.
This may be because they are playing a role as ookinete, oocyst or
hypnozoite function. Traditional hierarchical or k-means cluster-
ing is likely the best way to find out the function of these genes (see
companion web site). Finally, 296 were not considered differen-
tially expressed. Some of these may be upregulated in liver or
oocyst sporozoite stages or they may be silenced.
One of the more remarkable things about the gene expression
analysis is its robustness and insensitivity to sample contamination or
admixture. Our group contained few samples focused on early sexual
stage parasites and only a single zygote sample and yet we were able to
extract groups of genes from which we could extract a sexual
development transcription factor motif. Of course, the fact that we had
no oocyst salivary gland sporozoite or liver stages means that this
dataset is not comprehensive and more work will need to be done.
While P. vivax is by no means a model organisms the gene expression
data described here may be more useful for discovering motifs involved
in regulating transcription as the lower AT content may be less
problematic. It should also be noted that successes were not dependent
on having the larger structured Bozdech dataset as many of the motifs
could be extracted fromthe OPI clusters created with ourdata alone. A
group of genes enriched for those with roles in sexual development
(GO:PM16005087) could be extracted from our data when clustered
independently (7 of the 19 genes in a group of 172, p=10
25)a n dc o u l d
be used in motif finding. However no groups of genes enriched for ones
with roles in sexual development were found when the Bozdech data
was analyzed independently (See Supplemental Table 2). However,
when the datasets were combined, the quality of the cluster improved
(12 of the 19 genes in a group of 246, p=10
28)e v e nt h o u g ht h e
Bozdech samples were not predicted to contain sexual stage parasites.
Thus, more data and diversity is better.
These gene expression data for in vivo patient infections,
gametes/zygotes, ookinetes and sporozoites of the P. vivax parasite
provide an important foundation and reference for future studies.
Numerous differences in gene expression suggest many hypotheses
to be tested by researchers in the laboratory and in the field, and
may be used to guide drug treatment and vaccine development for
P. vivax. Further studies may provide correlations between in vivo
parasite gene expression variability between patient samples and
phenotypes of disease severity and drug resistance. In combination
with accurate drug treatment outcomes and patient data, we will
begin to identify the key determinants of the host-parasite
interactions in this important pathogen.
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